Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
抗がん剤の国内承認審査の傾向分析とトリプルネガティブ乳癌の代替エンドポイントの妥当性評価 ~新規抗がん剤の早期開発・早期承認と第三次予防の促進を目指して~
HTML
PDF
Details
Locations
Year:
2022
Type:
dissertation
Source:
Institutional Repositories DataBase (IRDB)
Author:
Hirai, Takehiro
Institution:
Teikyo University
Language:
Japanese
Topic:
Breast Cancer Treatment Studies
Subfield:
Cancer Research
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
triple-negative breast cancer,
surrogate endpoints,
early drug development
SDG:
Good health and well-being
Open Access status:
green
OpenAlex ID:
W7144794524
Cites:
46
Cited by:
Related to:
10